Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 09:25 am Unchanged |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
0 (Unchanged) |
Filing History |
| 2023-02-10 3:51 pm Purchase |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
4,420,349 (New Position) |
Filing History |
| 2023-02-10 1:20 pm Purchase |
2022-12-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,409,098 5.100% |
1,409,098 (New Position) |
Filing History |
| 2023-02-10 1:18 pm Purchase |
2022-12-30 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Kynam Capital Management, LP | 40,423,832 5.000% |
40,423,832 (New Position) |
Filing History |
| 2023-02-10 1:16 pm Purchase |
2022-12-30 | 13G | Burning Rock Biotech Limited BNR |
Kynam Capital Management, LP | 739,158 8.400% |
739,158 (New Position) |
Filing History |